July 18, 2007 -- China Shenghuo (AMEX: KUN) has completed a Phase II trial of its Wei DingKang Soft Capsules, a product that is being tested as a treatment for peptic ulcers. Results are expected in a few weeks. Like China Shenghuo’s other products, the Wei DingKang Soft Capsules are based on Sanchi, which are derived from Panax notoginseng root. China Shenghuo also intends to begin growing its own supply of the herb. More details...